期刊文献+

SD大鼠糖尿病创面与正常创面中TGF-β1、TGF-β3的表达差异 被引量:10

Different TGF-β1 and TGF-β3 expression in the granulation tissue of wound healing between normal and diabetic SD rats
暂未订购
导出
摘要 目的:通过观察大鼠正常创面与糖尿病模型创面肉芽组织中TGF-β1、TGF-β3不同时段表达水平的差异,探求糖尿病创面“难愈”的可能机制。方法:采用SD大鼠实验性正常创面及糖尿病创面背部全层皮肤缺损模型,分别于不同时段(3天、7天、11天)取材,EnVision二步法免疫组化测定,并行图像扫描定量分析TGF-β1、TGF-β3水平变化。结果:创伤后3天、7天和11天,正常创面模型组TGF-β1表达分别为(25.56±6.86)、(24.79±5.62)和(28.57±6.39),TGF-β3表达分别为(39.69±5.46)、(23.20±2.45)、(13.69±3.63)。而糖尿病溃疡模型组TGF-β1表达分别为(7.10±3.74)、(9.47±1.72)和(7.87±2.53),TGF-β3表达分别为(14.99±1.87)、(18.72±5.01)和(8.68±3.39)。糖尿病性创面肉芽组织中各时段(3天、7天和11天)TGF-β1及TGF-β3表达水平均低于正常创面组(P<0.05)。结论:SD大鼠糖尿病创面TGF-β1及TGF-β3的低水平表达,可能是创面愈合迟缓的原因之一。 Objective To study the different TGF-β1 and TGF-β3 expression of the granulation tissue between normal and diabetic SD rats in different wound healing periods. Methods After the establishment of full thickness dermal wounds of 2cm diameter inflicted on the SD rats back, the specimens were collected from the wound edge on the third.seventh and eleventh days after injury respectively. The specimens were subjected to immunohistochemical methods and image analysis of TGF-β1 and TGF-β3. Results On the third.seventh and eleventh day of wound healing respectively, TGF-β1 and TGF-β3 expressions in the granulation tissue of diabetic rats were much lower than those of the normal rats. Conclusion The lower level expressions of TGF-β1 and TGF-β3 in diabetic ulcer may be one cause of the difficulty wound healing.
出处 《中国美容医学》 CAS 2007年第1期35-37,共3页 Chinese Journal of Aesthetic Medicine
基金 国家自然科学基金资助项目(39900195) 上海市重点学科建设项目资助项目(T0304)
关键词 糖尿病 创面愈合 TGFΒ diabetes wound healing TGFβ
  • 相关文献

参考文献10

二级参考文献65

  • 1程飚,付小兵,盛志勇,孙同柱,孙晓庆,李建福.瘢痕形成的分子机制初探:瘢痕组织与成人正常皮肤中EGFR与FGFR2表达差异的对比[J].中国组织工程研究与临床康复,2001,10(20):66-67. 被引量:2
  • 2程飙,付小兵,盛志勇,孙同柱,孙晓庆,李建福.创伤修复中细胞信号传递对瘢痕形成的影响:SH2功能领域蛋白酪氨酸磷酸酶的表达及意义[J].中国组织工程研究与临床康复,2001,10(22):50-51. 被引量:4
  • 3[1]Green MF, Aliabadi Z, Green BT. Diabetic foot: evaluation and management. South Med J 2002; 95 ( 1 ): 95 - 101
  • 4[2]Baumeister S, Dragu A, Jester A, et al. The role of plastic and reconstructive surgery within an interdisciplinary treatment concept for diabetic ulcers of the foot. Dtsch Med Wochenschr 2004; 129 ( 13 ): 676 - 80
  • 5[3]Cunha BA. Antibiotic selection for diabetic foot infections: a review. J Foot Ankle Surg 2000; 39(4): 253 - 7
  • 6[5]Valk GD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration. Endocrinol Metab Clin North Am 2002; 31 (3): 633 - 58
  • 7[6]Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981; 2:64 - 122
  • 8[8]Vayssairat M, Le Devehat C. Critical analysis of vascular explorations in diabetic complications. J Mal Vasc 2001; 26 (2): 122 - 5
  • 9[9]Harding KG, Jones V, Price P. Topical treatment: which dressing to choose. Diabetes Metab Res Rev 2000; 16(Suppl 1): S47 -50
  • 10[10]Bakker K, Schaper NC. New developments in the treatment of diabetic foot ulcers. Ned Tijdschr Geneeskd 2000; 144(9): 409 - 12

共引文献216

同被引文献112

引证文献10

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部